Longevity Medicine
Graduate School of Health and Medical Sciences at University of Copenhagen
This course is free of charge for PhD students at Danish universities (except Copenhagen Business School), and for PhD Students from NorDoc member faculties. All other participants must pay the course fee.
Anyone can apply for the course, but if you are not a PhD student at a Danish university, you will be placed on the waiting list until enrollment deadline. This also applies to PhD students from NorDoc member faculties. After the enrollment deadline, available seats will be allocated to applicants on the waiting list.
Learning objectives
A student who has met the objectives of the course will be able to:
1. To attain knowledge of the various facets of the biology of aging and longevity and the relationship between them.
2. To understand some of the major diseases of aging, and their etiologies in the underlying biology of aging.
3. To attain knowledge and skills in how to design clinical trials involving longevity interventions.
Content
Why do we age? And can we use modern medicine to make us healthier for a longer period of time? In the Longevity Medicine course we attempt to answer this question. Longevity medicine is a fast-evolving field and it is currently outpacing the ability of the medical practice to internalize and implement the progress of related research. Modern advances in AI and machine learning, biomarker research and drug development have produced numerous tools for early diagnostics and prevention, which remain unknown to the global medical community. The paradigm of longevity and healthy aging as the top priority will undoubtedly greatly impact the primary, secondary and tertiary prevention rates.
What Will You Learn?
• A basic introduction to the underlying mechanisms of aging and longevity.
• The role of aging in a variety of diseases and the physiological consequence of aging.
• How to measure aging - introduction to the emerging science of aging clocks and deep aging clocks.
• Behavioral interventions targeting aging.
• What are the recent clinical efforts and applications in aging and longevity?
• How do we design the next generation of drugs for aging?
• Further aging and longevity public information resources and conferences.
Participants
Medicine, biology, biochemistry and other life science PhDs.
Relevance to graduate programmes
The course is relevant to PhD students from the following graduate programmes at the Graduate School of Health and Medical Sciences, UCPH:
All graduate programmes
Language
English
Form
Lectures (online and onsite)
Group work
Discussions
Presentations
Course director
Morten Scheibye-Knudsen
Associate professor, ICMM
Teachers
Morten Scheibye-Knudsen (trial design) (UCPH)
Lene Juel Rasmussen (hallmarks of aging) (UCPH)
Charlotte Suetta (skeletal muscle) (Bispebjerg hospital)
Luigi Ferrucci (human aging) (NIA-NIH)
Alex Zhavoronkov (drug design) (Insilico Medicine)
Kaare Christensen (extreme aging) (SDU)
Sarah Hägg (drug interventions) (Karolinska)
Jan Nehlin (senotherapeutics) (Amager-Hvidovre hospital)
James Kirkland (clinical trials) (Mayo clinic)
Evandro Fang (drug design) (UiO)
Dates
18, 19 and 20 November 2024
All days 10:00 – 17:00
Course location
Panum Institute, University of Copenhagen
Registration
Please register before 18 October 2024.
Expected frequency
Once a year
Seats to PhD students from other Danish universities will be allocated on a first-come, first-served basis and according to the applicable rules.
Applications from other participants will be considered after the last day of enrolment.
Note: All applicants are asked to submit invoice details in case of no-show, late cancellation or obligation to pay the course fee (typically non-PhD students). If you are a PhD student, your participation in the course must be in agreement with your principal supervisor.